|This Slide: #6 of 100|
Slide #6. ICON — Aptiv Solutions
ICON plc, (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has completed the previously announced acquisition of Aptiv Solutions.
Icon is a clinical research organization. Co. operates as one business segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries. Co. provides a range of clinical, consulting and commercial services that range from clinical development strategy, planning and trial design, to full study execution, and post-market commercialization. Co. engages in the development, management and analysis of programs that support various stages of the clinical development process. Co. provides services including clinical trial management, consulting, contract staffing and laboratory services.
Open the ICLR Page at The Online Investor »
Buy (3.17 out of 4)